147 related articles for article (PubMed ID: 8116074)
1. Neoplasms of unknown primary site: a clinicopathological study of autopsied patients.
Mayordomo JI; Guerra JM; Guijarro C; García-Prats MD; Gómez A; López-Brea M; González R; Hergueta P; López-Pino MA; Martínez-Tello F
Tumori; 1993 Oct; 79(5):321-4. PubMed ID: 8116074
[TBL] [Abstract][Full Text] [Related]
2. The value of postmortem examination in cases of metastasis of unknown origin-20-year retrospective data from a tertiary care center.
Al-Brahim N; Ross C; Carter B; Chorneyko K
Ann Diagn Pathol; 2005 Apr; 9(2):77-80. PubMed ID: 15806513
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
[TBL] [Abstract][Full Text] [Related]
4. Cancer of unknown primary: clinicopathologic correlations.
Blaszyk H; Hartmann A; Bjornsson J
APMIS; 2003 Dec; 111(12):1089-94. PubMed ID: 14678017
[TBL] [Abstract][Full Text] [Related]
5. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
Pentheroudakis G; Golfinopoulos V; Pavlidis N
Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
[TBL] [Abstract][Full Text] [Related]
6. Poorly differentiated neoplasms of unknown primary site: diagnostic usefulness of a molecular cancer classifier assay.
Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
Mol Diagn Ther; 2015 Apr; 19(2):91-7. PubMed ID: 25758902
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver.
Yang Z; Klimstra DS; Hruban RH; Tang LH
Am J Surg Pathol; 2017 Jul; 41(7):915-922. PubMed ID: 28498280
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
9. Malignancies of undetermined primary origin.
Bitran JD; Ultmann JE
Dis Mon; 1992 Apr; 38(4):213-60. PubMed ID: 1547698
[TBL] [Abstract][Full Text] [Related]
10. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
Schapira DV; Jarrett AR
Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
[TBL] [Abstract][Full Text] [Related]
11. Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study.
Katagiri H; Takahashi M; Inagaki J; Sugiura H; Ito S; Iwata H
Cancer; 1999 Aug; 86(3):533-7. PubMed ID: 10430264
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.
Tot T
Cancer; 1999 Jan; 85(1):171-7. PubMed ID: 9921990
[TBL] [Abstract][Full Text] [Related]
14. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases.
Jacobsen S; Stephensen SL; Paaske BP; Lie PG; Lausten GS
Acta Orthop Belg; 1997 Mar; 63(1):15-22. PubMed ID: 9151454
[TBL] [Abstract][Full Text] [Related]
15. [An analysis of autopsy cases with cancer of unknown primary site].
Mandai K; Moriwaki S; Yamagami K; Saeki T; Yamauchi M
Rinsho Byori; 1994 Jan; 42(1):75-82. PubMed ID: 8107286
[TBL] [Abstract][Full Text] [Related]
16. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients.
Le Chevalier T; Cvitkovic E; Caille P; Harvey J; Contesso G; Spielmann M; Rouesse J
Arch Intern Med; 1988 Sep; 148(9):2035-9. PubMed ID: 3046543
[TBL] [Abstract][Full Text] [Related]
17. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature.
Adsay NV; Andea A; Basturk O; Kilinc N; Nassar H; Cheng JD
Virchows Arch; 2004 Jun; 444(6):527-35. PubMed ID: 15057558
[TBL] [Abstract][Full Text] [Related]
18. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract][Full Text] [Related]
19. Secondary tumors of the pancreas: clinicopathological study of 103 autopsy cases of Japanese patients.
Nakamura E; Shimizu M; Itoh T; Manabe T
Pathol Int; 2001 Sep; 51(9):686-90. PubMed ID: 11696171
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?
Catena L; Bichisao E; Milione M; Valente M; Platania M; Pusceddu S; Ducceschi M; Zilembo N; Formisano B; Bajetta E
Tumori; 2011; 97(5):564-7. PubMed ID: 22158484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
